Simon Englund

Stockholm, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss.

Use of Symptomatic Drug Treatment for Fatigue in Multiple Sclerosis and Patterns of Work Loss.

Journal: Annals of clinical and translational neurology

Published: September 22, 2025

Multi-coincidence set-up for nuclear forensics with Si-strip and Compton-suppressed HPGe detectors.

Multi-coincidence set-up for nuclear forensics with Si-strip and Compton-suppressed HPGe detectors.

Journal: Journal of environmental radioactivity

Published: July 22, 2025

COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab.

COMBAT-MS: A Population-Based Observational Cohort Study Addressing the Benefit-Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab.

Journal: Annals of neurology

Published: February 20, 2024

Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy.

Trajectories of self-reported fatigue following initiation of multiple sclerosis disease-modifying therapy.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: February 09, 2024

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.

Trajectories of cognitive processing speed and physical disability over 11 years following initiation of a first multiple sclerosis disease-modulating therapy.

Journal: Journal of neurology, neurosurgery, and psychiatry

Published: May 08, 2023

Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study.

Multiple sclerosis, disease-modifying drugs and risk for adverse perinatal and pregnancy outcomes: Results from a population-based cohort study.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: April 19, 2023

High-intensity resistance training in people with multiple sclerosis experiencing fatigue: A randomised controlled trial.

High-intensity resistance training in people with multiple sclerosis experiencing fatigue: A randomised controlled trial.

Journal: Multiple sclerosis and related disorders

Published: July 01, 2022

COVID-19 clinical outcomes and DMT of MS patients and population-based controls.

COVID-19 clinical outcomes and DMT of MS patients and population-based controls.

Journal: Annals of clinical and translational neurology

Published: June 27, 2022

Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort.

Predictors of patient-reported fatigue symptom severity in a nationwide multiple sclerosis cohort.

Journal: Multiple sclerosis and related disorders

Published: April 05, 2022

Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden.

Rituximab Infusion Timing, Cumulative Dose, and Hospitalization for COVID-19 in Persons With Multiple Sclerosis in Sweden.

Journal: JAMA network open

Published: December 01, 2021

Risk of depression in multiple sclerosis across disease-modifying therapies.

Risk of depression in multiple sclerosis across disease-modifying therapies.

Journal: Multiple sclerosis (Houndmills, Basingstoke, England)

Published: July 15, 2021

Can health behaviours prolong survival and compress the period of survival with the disability? A population-based cohort study.

Can health behaviours prolong survival and compress the period of survival with the disability? A population-based cohort study.

Journal: Age and ageing

Published: March 18, 2020

Showing 1-12 of 14

Last Updated: 09/26/2026